The Money Report with Dave Gentry -E03- Biotechnology
"The RedChip Money Report" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. The third episode features executive interviews with Galectin Therapeutics (NasdaqCM: GALT), ChromaDex Corp. (OTC BB: CDXC), NeoStem (NYSE: NBS), and Galena BioPharma (NasdaqCM: GALE). The show also features a segment on Echo Therapeutics (NasdaqCM: ECTE). Visit http://www.RedChip.com for more information.From:redchipuserViews:5 0ratingsTime:24:24More inNews Politics
See more here:
The Money Report with Dave Gentry -E03- Biotechnology - Video
Recommendation and review posted by G. Smith
